[ad_1]
An intriguing group of individuals appears immune to the cognitive effects of Alzheimer’s disease, even though their brains exhibit the defining signs of this condition.
The curiosity to unravel the mysteries behind this group’s resilience has drawn considerable attention from the scientific community.
Alzheimer’s disease, which stands as the predominant cause of dementia, is suspected to arise due to an accumulation of two proteins in the brain: amyloid and tau.
These proteins become problematic when they reach toxic levels, resulting in neuronal death. The loss of these brain cells leads to the hallmark symptoms of Alzheimer’s, notably memory decline and impaired cognition.
Over the years, this sequence of events has been recognized as the typical progression in Alzheimer’s patients.
However, there exists a peculiar subset of individuals who demonstrate remarkable resilience against such progression. But what is their secret?
A study detailed in Acta Neuropathologica Communications sought to explore the potential genetic influence on an individual’s resilience to Alzheimer’s symptoms when high levels of amyloid are present in the brain.
The research involved examining the brains from three distinct cohorts. The first group encompassed subjects who passed away due to Alzheimer’s disease.
The second group included individuals who died from other natural causes but were otherwise healthy. The third group was particularly interesting, consisting of those with substantial Alzheimer’s-associated protein levels in their brains but no manifested symptoms of the condition—or at least, no Alzheimer’s diagnosis during their lives.
This final group was considered resilient to Alzheimer’s, for despite the presence of tell-tale proteins, they showed no clinical symptoms or diagnosis.
Researchers discovered that genes regulating immune system activity were notably more engaged in the brains of the resilient group.
Since the immune system is known to assist in clearing out excess proteins from the brain, genes facilitating this process are likely contributors to heightened resilience against Alzheimer’s development.
Bolstering Resilience Against Alzheimer’s Without Genetic Favor
If you have not inherited resilience-boosting genes, is there still hope for heightened Alzheimer’s resistance?
The encouraging response is “Yes.”
Emerging scientific evidence proposes that lifestyle modifications and medications can potentially reduce Alzheimer’s risk factors.
Physical exercise, in particular, has shown efficacy in diminishing Alzheimer’s likelihood through its positive impact on the immune system and consequent protein clearance from the brain.
Thus, increased physical activity may emulate the resilience effects observed in genetically fortunate individuals.
An unresolved question, however, is: How did the lifestyle, such as physical activity levels, of the resilient study participants play into their apparent immunity to Alzheimer’s?
As is typical in science, the debate ensues whether resilience is more a product of genetics (nature) or environmental factors and personal choices (nurture).
An additional consideration is that the resilient individuals from the study died of causes other than Alzheimer’s disease. It remains uncertain whether they would have ultimately succumbed to Alzheimer’s symptoms had they lived longer.
Michael Hornberger, Professor of Applied Dementia Research, University of East Anglia
This article is republished from The Conversation under a Creative Commons license. Read the original article.
[ad_2]
FAQ: Understanding Alzheimer’s Resilience
Q: Can a person have Alzheimer’s disease markers but not the symptoms?
A: Yes, it has been observed that some individuals show biological markers of Alzheimer’s in the brain but do not exhibit the cognitive symptoms typically associated with the disease.
Q: What could make a person resilient to Alzheimer’s disease?
A: Research indicates that genes related to immune system activity may play a role in resilience. Additionally, lifestyle choices, especially regular physical activity, may also contribute to enhanced resistance against developing Alzheimer’s disease symptoms.
Q: How significant is lifestyle in potentially reducing the risk of Alzheimer’s?
A: Lifestyle is believed to be quite important. Engaging in regular physical exercise, in particular, has been shown to benefit the immune system, which can help clear excess amyloid and tau proteins that are linked to Alzheimer’s pathology.
Q: Can medication prevent or delay Alzheimer’s?
A: While there is no definitive cure for Alzheimer’s, certain medications and therapeutic interventions can slow the progression of the disease and improve symptoms. Prevention strategies are an active area of research.
Q: Is Alzheimer’s resilience more dependent on genetics or lifestyle?
A: Both genetics and lifestyle appear to play a role in Alzheimer’s resilience, although it is not yet clear to what extent each factor contributes. It is the interplay between the two that likely determines an individual’s level of resilience.
